Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial Of The Micronized dHACM Injection As Compared To Saline Placebo Injection In The Treatment Of Achilles Tendonitis

NCT03414255 is registered in ClinicalTrials.gov with MiMedx Group, Inc. as lead sponsor.

NCT NCT03414255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03414255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial Of The Micronized dHACM Injection As Compared To Saline Placebo Injection In The Treatment Of Achilles Tendonitis
Lead sponsor
MiMedx Group, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 9, 2018
Completion date
March 30, 2021
Enrollment
146 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

tendonitis;achilles